Q3 2025 Clover Health Investments Corp Earnings Call Transcript

Nov 4, 2025 / 10:00 PM GMT

Release Date Price: $3.52 (-4.35%)

Transcript 10-Q

Key Points

Positve

Clover Health Investments Corp (CLOV) achieved a 35% year-over-year growth in membership and a 49% increase in insurance revenue.
The company maintained positive adjusted EBITDA and adjusted net income year-to-date, demonstrating resilience despite challenges.
Clover Assistant continues to drive strong clinical quality scores, making CLOV the top PPO in the country for the second year running.
The company anticipates meaningful adjusted EBITDA profitability starting in 2026, driven by a larger base of returning members.
Clover Health Investments Corp (CLOV) is expanding its technology capabilities, including integrated scribing and generative AI tools, to enhance physician efficiency and patient care.

Negative

Clover Health Investments Corp (CLOV) missed its targets on overall adjusted EBITDA and star ratings, which are not acceptable to the company.
The company faced significant margin pressure due to a higher than expected proportion of new members, which are generally loss-making in the first year.
Increased utilization across medical expenses and supplemental benefits contributed to reduced adjusted EBITDA profitability.
Clover Health Investments Corp (CLOV) received a 3.5-star rating for the 2026 ratings year, which does not meet the company's aspiration for a 4-star plan.
The company experienced higher medical cost trends, particularly in inpatient and outpatient services, impacting financial performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CLOV.OQ - Clover Health Investments Corp
Q3 2025 Clover Health Investments Corp Earnings Call
Nov 04, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to Clover Health's 3rd quarter 2025 earnings call.

We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for the question-and-answer session.

Also, as a reminder, this conference is being recorded today. If you have any objections, please disconnect at this time.

Ryan, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon everyone. Joining me on our call today to discuss the company's 3rd quarter 2025 results are

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.